Julian Koenig is an expert in Psychiatry at University Hospital Cologne (Germany). Julian Koenig has authored 369 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 1,126 (community average: 125). How the SLR is computed.

LeadR Profile

Julian Koenig University Hospital Cologne Germany
1 126 ScienceLeadR Reputation 1126
Network Map

Psychiatry

Subspecialties: Pediatrics - Psychology - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026

Source: PubMed

SRH Hochschule Heidelberg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 369

Citations

Citations: 10 072 1st author: 62 Last author: 63 Unique author: 8


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Longitudinal changes in endocannabinoids and clinical course of adolescent non-suicidal self-injury.
PMID 42693114 — biomarkers, signs and symptoms, adolescent, endocannabinoids, therapeutics, self-injurious behavior, psychiatry
Transl Psychiatry20260
Effectiveness of an interactive music tablet intervention to reduce procedural anxiety in children: a randomized controlled trial.
PMID 42637802 — caregivers, tablets, aged, child
Sci Rep20260
Biobehavioral synchrony between three to four months old infants and psychologically healthy mothers during the face-to-face still-face paradigm.
PMID 42557292 — mothers, emotions, heart, stress, physiological, infant
Sci Rep20260
Thymus Involution across the Human Menstrual Cycle.
PMID 42539218 — menstrual cycle, parturition, hormonal contraception, estradiol, tomography, contraception, hormones, thymus gland, luteal phase, contraceptive agents, progesterone
bioRxiv20260
The autonomic nervous system-lung interface in experimental BPD: NPY modulates immune response, alveolar growth and vascular muscularizationin neonatal mice exposed to oxidative stress.
PMID 42387502 — cells, autonomic nervous system, lung, growth, macrophages, stress, physiological, respiratory physiological phenomena, hyperoxia, oxidative stress, immunity, nervous system
Respir Res20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 5

By status:

Completed 3
Recruiting 2

By type:

Interventional 4
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 3
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Sleep in Psychiatric Care (SIP) Treatment for Comorbid Delayed Sleep Wake Phase Disorder (DSWPD)
NCT05177055 — hygiene, sleep hygiene, circadian rhythm, sleep, mental disorders, ambulatory care facilities, schools, methamphetamine, sleep disorders, circadian rhythm, eyeglasses, phototherapy, therapeutics, outpatients, education, problem behavior, parasomnias, sleep wake disorders, cognitive restructuring
N/ARecruiting2022
Sleep in Psychiatric Care (SIP) A Transdiagnostic Group based Sleep school as Treatment for Comorbid Insomnia
NCT04463498 — sleep, mental disorders, ambulatory care facilities, schools, methamphetamine, maintenance, eyeglasses, therapeutics, outpatients, education, problem behavior, parasomnias, sleep initiation and maintenance disorders, cognitive behavioral therapy, sleep wake disorders, cognitive restructuring
N/ARecruiting2021

LeadR Networks

Main global connection map